- Dubai Science Park, Dubai, United Arab Emirates
Biomedix – Biomedix is a development-stage company established in 2008, pursing commercial opportunities in field of biotechnology and in-vitro kits. The company provides training courses for required staff working in PCR laboratory .We also distribute high quality, low price in-vitro diagnostic kits and reagents for PCR and Elisa. The company is the representative of BioQControl for Iran, Iraq, Saudi Arabia, India, Pakistan, Egypt, Jordan and Syria for the proficiency panels for NAT and Elisa .We also provide a unique biomaterial (Alloplant) for ophthalmology.
The general director of the company has 34 years of experience working in diagnostic laboratory including seventeen years working in managerial positions in field of invitro diagnostic kits and reagents. The company enjoys having access to senior scientists in fields of biotechnology, invitro diagnostic and related quality control.
In-vitro diagnostic Kits
Avicenna EIA , HIV1+2 Ag/Ab ( Fourth generation)
Avicenna EIA-HIV1+2 Ag/Ab test system is a qualitative, enzyme immunoassay for the detection of circulating antibodies to Human Immunodeficiency Virus type 1(HIV1) and /or Human Immunodeficiency Virus Type 2(HIV2) in human serum or plasma and detection of p24 core antigen of HIV virus Type 1.
Human Immunodeficiency Virus Type (HIV1) has been isolated from patients with AIDS and AIDS –related complex (ARC). HIV-1 was thought to be the only causative agent of these syndromes until 1986, when a second type of Human Immunodeficiency Virus (HIV2) was isolated and also reported to cause AIDS. Since the initial discovery more than few hundred cases of HIV-2 infection have been documented worldwide. Both viruses have the same morphology and lymphotropism, and the modes of transmission appear to be identical. In addition, HIV1 and HIV2 genomes exhibit about 60% homology in conserved genes such as gag and pol. Serologic studies have also shown that the core proteins of HIV–1 and HIV-2 display frequent cross-reactivity whereas the envelope proteins are more type-specific.Despite this immunologic cross-reactivity, detection of antibodies to HIV-2 with any of the licensed HIV-1 enzyme immunoassay is highly variable. This device was developed to detect antibodies to HIV-1 and HIV-2 for blood screening and diagnostic purposes.The human monoclonal used in the new generation HIV screening test have been shown to be insensitive to high titters of rheumatoid factors and not reacting to serum with HAMA.
Biomedix FZ LLC
United Arab Emirates